HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of the radioimmunoprecipitation-PEG assay (RIPEGA) to detect anti-IgG antibodies.

Abstract
A new procedure, the radioimmunoprecipitation--P.E.G. assay (RIPEGA) is proposed for the detection of anti-IgG antibodies (anti-IgG Ab). This sensitive and reproducible test was performed by incubation of radio-labelled human IgG (125I-IgG) with patient's sera. Separation of free from complexed 125I-IgG was achieved by a 7% P.E.G. precipitation. Preliminary results demonstrated anti-IgG Ab in 84.4% of the cases of sero-positive rheumatoid arthritis (R.A.), 85% of seronegative R.A., 43% of other forms of inflammatory arthritis, 50% of unclassified arthritis and in 10.5% of the control subjects.
AuthorsF Santoro, B Duquesnoy, P Wattre, B Delcambre, A Capron
JournalBiomedicine / [publiee pour l'A.A.I.C.I.G.] (Biomedicine) Vol. 27 Issue 6 Pg. 230-3 (Jul 1977) ISSN: 0300-0893 [Print] France
PMID907801 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin G
  • Polyethylene Glycols
  • Rheumatoid Factor
Topics
  • Arthritis, Rheumatoid (diagnosis, immunology)
  • Humans
  • Immunoglobulin G
  • Polyethylene Glycols
  • Precipitin Tests (methods)
  • Rheumatoid Factor (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: